|
시장보고서
상품코드
1583592
세계의 성감염증(STD) 검사 시장(2024-2028년)Global Sexually Transmitted Disease (STD) Testing Market 2024-2028 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
성감염증(STD) 검사 시장(2024-2028년)
성감염증(STD) 검사 시장은 2023-2028년에 323억 7,000만 달러로 확대하며, 예측 기간 중 5.6%의 CAGR로 성장할 것으로 예측됩니다. 성감염증(STD) 검사 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25사의 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 이 시장은 STD의 유병률 증가, 유리한 상환 정책의 존재, 세계 각국 정부에 의한 구상의 증가에 의해 촉진되고 있습니다.
| 시장 범위 | |
|---|---|
| 기준년 | 2024년 |
| 종료년 | 2028년 |
| 예측 기간 | 2024-2028년 |
| 성장 모멘텀 | 가속 |
| 전년대비(2024년) | 5.22% |
| CAGR | 5.6% |
| 증분액 | 323억 7,000만 달러 |
향후 수년간 성감염증(STD) 검사 시장의 성장을 촉진하는 주요 요인의 하나로 성병의 신속 진단의 진보를 들고 있습니다. 또한 STD 및 신속 파트너 요법(EPT)에 관한 인식을 높이기 위해 다양한 조직의 관여가 증가하고 있는 것도 시장의 큰 수요로 연결됩니다.
목차
제1장 개요
- 시장 개요
제2장 시장 구도
- 시장 에코시스템
- 시장의 특징
- 밸류체인 분석
제3장 시장 규모의 평가
- 시장의 정의
- 시장 부문 분석
- 시장 규모(2023년)
- 시장 전망(2023-2028년)
제4장 시장 규모 실적
- 세계의 성감염증(STD) 검사 시장(2018-2022년)
- 제품별 분석(2018-2022년)
- 질환 유형별 분석(2018-2022년)
- 지역별 분석(2018-2022년)
- 국가별 분석(2018-2022년)
제5장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 현황
제6장 제품별 시장 세분화
- 시장 세분화
- 비교 : 제품별
- 검사실 검사 기기 : 시장 규모와 예측(2023-2028년)
- PoC 검사 기기 : 시장 규모와 예측(2023-2028년)
- 제품별 시장 기회
제7장질환 유형별 시장 세분화
- 시장 세분화
- 비교 : 질환 유형별
- 클라미디아 : 시장 규모와 예측(2023-2028년)
- 임질 : 시장 규모와 예측(2023-2028년)
- 매독 : 시장 규모와 예측(2023-2028년)
- 트리코모나스증 : 시장 규모와 예측(2023-2028년)
- 기타 : 시장 규모와 예측(2023-2028년)
- 질환 유형별 시장 기회
제8장 고객 상황
- 고객 상황의 개요
제9장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측(2023-2028년)
- 유럽 : 시장 규모와 예측(2023-2028년)
- 아시아 : 시장 규모와 예측(2023-2028년)
- 세계의 기타 지역 : 시장 규모와 예측(2023-2028년)
- 미국 : 시장 규모와 예측(2023-2028년)
- 독일 : 시장 규모와 예측(2023-2028년)
- 영국 : 시장 규모와 예측(2023-2028년)
- 캐나다 : 시장 규모와 예측(2023-2028년)
- 중국 : 시장 규모와 예측(2023-2028년)
- 지역별 시장 기회
제10장 촉진요인·과제·기회·억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 촉진요인과 과제의 영향
- 시장의 기회·억제요인
제11장 경쟁 구도
- 개요
- 경쟁 구도
- 혼란 상황
- 업계의 리스크
제12장 경쟁 분석
- 기업 개요
- 기업의 시장 포지셔닝
- AbbVie Inc.
- AccuBioTech Co. Ltd.
- AdvaCare Pharma
- BIOGENIX Inc. Pvt. Ltd.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Hologic Inc.
- Inovio Pharmaceuticals Inc.
- Johnson and Johnson Services Inc.
- Merck and Co. Inc.
- Ok Biotech Co Ltd.
- Priority STD Testing
- QIAGEN NV
- RayBiotech Life Inc.
제13장 부록
KSA 24.11.22Sexually Transmitted Disease (STD) Testing Market 2024-2028
The sexually transmitted disease (STD) testing market is forecasted to grow by USD 32.37 bn during 2023-2028, accelerating at a CAGR of 5.6% during the forecast period. The report on the sexually transmitted disease (STD) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of STDs, presence of favorable reimbursement policies, and increased initiatives by governments worldwide.
| Market Scope | |
|---|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 5.22% |
| CAGR | 5.6% |
| Incremental Value | $32.37 bn |
Technavio's sexually transmitted disease (STD) testing market is segmented as below:
By Product
- Laboratory testing device
- POC testing device
By Disease Type
- Chlamydia
- Gonorrhea
- Syphilis
- Trichomoniasis
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the advances in rapid diagnosis of STDs as one of the prime reasons driving the sexually transmitted disease (STD) testing market growth during the next few years. Also, increasing involvement of various organizations to create awareness about STDs and expedited partner therapy (EPT) will lead to sizable demand in the market.
The report on the sexually transmitted disease (STD) testing market covers the following areas:
- Sexually transmitted disease (STD) testing market sizing
- Sexually transmitted disease (STD) testing market forecast
- Sexually transmitted disease (STD) testing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sexually transmitted disease (STD) testing market vendors that include AbbVie Inc., AccuBioTech Co. Ltd., AdvaCare Pharma, BIOGENIX Inc. Pvt. Ltd., CTK Biotech Inc., Everlywell Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline PLC, Goffin Molecular Technologies, Hangzhou Biotest Biotech, Hologic Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., LT Labs, Merck and Co. Inc., Ok Biotech Co Ltd., Priority STD Testing, QIAGEN NV, and RayBiotech Life Inc.. Also, the sexually transmitted disease (STD) testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Disease Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
- Value Chain Analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Sexually Transmitted Disease (STD) Testing Market 2018 - 2022
- Historic Market Size - Data Table on Global Sexually Transmitted Disease (STD) Testing Market 2018 - 2022 ($ billion)
- 4.2 Product segment analysis 2018 - 2022
- Historic Market Size - Product Segment 2018 - 2022 ($ billion)
- 4.3 Disease Type segment analysis 2018 - 2022
- Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion)
- 4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
- 4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
- 6.1 Market segments
- Chart on Product - Market share 2023-2028 (%)
- Data Table on Product - Market share 2023-2028 (%)
- 6.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 6.3 Laboratory testing device - Market size and forecast 2023-2028
- Chart on Laboratory testing device - Market size and forecast 2023-2028 ($ billion)
- Data Table on Laboratory testing device - Market size and forecast 2023-2028 ($ billion)
- Chart on Laboratory testing device - Year-over-year growth 2023-2028 (%)
- Data Table on Laboratory testing device - Year-over-year growth 2023-2028 (%)
- 6.4 POC testing device - Market size and forecast 2023-2028
- Chart on POC testing device - Market size and forecast 2023-2028 ($ billion)
- Data Table on POC testing device - Market size and forecast 2023-2028 ($ billion)
- Chart on POC testing device - Year-over-year growth 2023-2028 (%)
- Data Table on POC testing device - Year-over-year growth 2023-2028 (%)
- 6.5 Market opportunity by Product
- Market opportunity by Product ($ billion)
- Data Table on Market opportunity by Product ($ billion)
7 Market Segmentation by Disease Type
- 7.1 Market segments
- Chart on Disease Type - Market share 2023-2028 (%)
- Data Table on Disease Type - Market share 2023-2028 (%)
- 7.2 Comparison by Disease Type
- Chart on Comparison by Disease Type
- Data Table on Comparison by Disease Type
- 7.3 Chlamydia - Market size and forecast 2023-2028
- Chart on Chlamydia - Market size and forecast 2023-2028 ($ billion)
- Data Table on Chlamydia - Market size and forecast 2023-2028 ($ billion)
- Chart on Chlamydia - Year-over-year growth 2023-2028 (%)
- Data Table on Chlamydia - Year-over-year growth 2023-2028 (%)
- 7.4 Gonorrhea - Market size and forecast 2023-2028
- Chart on Gonorrhea - Market size and forecast 2023-2028 ($ billion)
- Data Table on Gonorrhea - Market size and forecast 2023-2028 ($ billion)
- Chart on Gonorrhea - Year-over-year growth 2023-2028 (%)
- Data Table on Gonorrhea - Year-over-year growth 2023-2028 (%)
- 7.5 Syphilis - Market size and forecast 2023-2028
- Chart on Syphilis - Market size and forecast 2023-2028 ($ billion)
- Data Table on Syphilis - Market size and forecast 2023-2028 ($ billion)
- Chart on Syphilis - Year-over-year growth 2023-2028 (%)
- Data Table on Syphilis - Year-over-year growth 2023-2028 (%)
- 7.6 Trichomoniasis - Market size and forecast 2023-2028
- Chart on Trichomoniasis - Market size and forecast 2023-2028 ($ billion)
- Data Table on Trichomoniasis - Market size and forecast 2023-2028 ($ billion)
- Chart on Trichomoniasis - Year-over-year growth 2023-2028 (%)
- Data Table on Trichomoniasis - Year-over-year growth 2023-2028 (%)
- 7.7 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
- 7.8 Market opportunity by Disease Type
- Market opportunity by Disease Type ($ billion)
- Data Table on Market opportunity by Disease Type ($ billion)
8 Customer Landscape
- 8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ billion)
- Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ billion)
- Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 9.11 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ billion)
- Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ billion)
- Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Opportunity/Restraints
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 10.4 Market opportunities/restraints
11 Competitive Landscape
- 11.1 Overview
- 11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 11.3 Landscape disruption
- Overview on factors of disruption
- 11.4 Industry risks
- Impact of key risks on business
12 Competitive Analysis
- 12.1 Companies profiled
- Companies covered
- 12.2 Market positioning of companies
- Matrix on companies position and classification
- 12.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- 12.4 AccuBioTech Co. Ltd.
- AccuBioTech Co. Ltd. - Overview
- AccuBioTech Co. Ltd. - Product / Service
- AccuBioTech Co. Ltd. - Key offerings
- 12.5 AdvaCare Pharma
- AdvaCare Pharma - Overview
- AdvaCare Pharma - Product / Service
- AdvaCare Pharma - Key offerings
- 12.6 BIOGENIX Inc. Pvt. Ltd.
- BIOGENIX Inc. Pvt. Ltd. - Overview
- BIOGENIX Inc. Pvt. Ltd. - Product / Service
- BIOGENIX Inc. Pvt. Ltd. - Key offerings
- 12.7 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- 12.8 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
- 12.9 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- 12.10 Hologic Inc.
- Hologic Inc. - Overview
- Hologic Inc. - Business segments
- Hologic Inc. - Key news
- Hologic Inc. - Key offerings
- Hologic Inc. - Segment focus
- 12.11 Inovio Pharmaceuticals Inc.
- Inovio Pharmaceuticals Inc. - Overview
- Inovio Pharmaceuticals Inc. - Product / Service
- Inovio Pharmaceuticals Inc. - Key news
- Inovio Pharmaceuticals Inc. - Key offerings
- 12.12 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- 12.13 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- 12.14 Ok Biotech Co Ltd.
- Ok Biotech Co Ltd. - Overview
- Ok Biotech Co Ltd. - Product / Service
- Ok Biotech Co Ltd. - Key offerings
- 12.15 Priority STD Testing
- Priority STD Testing - Overview
- Priority STD Testing - Product / Service
- Priority STD Testing - Key offerings
- 12.16 QIAGEN NV
- QIAGEN NV - Overview
- QIAGEN NV - Product / Service
- QIAGEN NV - Key news
- QIAGEN NV - Key offerings
- 12.17 RayBiotech Life Inc.
- RayBiotech Life Inc. - Overview
- RayBiotech Life Inc. - Product / Service
- RayBiotech Life Inc. - Key offerings
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 13.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 13.4 Research methodology
- Research methodology
- 13.5 Data procurement
- Information sources
- 13.6 Data validation
- Data validation
- 13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 13.8 Data synthesis
- Data synthesis
- 13.9 360 degree market analysis
- 360 degree market analysis
- 13.10 List of abbreviations
- List of abbreviations
샘플 요청 목록